Search Results - "Ansarifar, Akram"
-
1
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
Published in International immunopharmacology (01-06-2021)“…•Favipiravir does not reduce number of ICU admissions or intubations or in-hospital mortality.•Favipiravir does not shorten time to clinical recovery and…”
Get full text
Journal Article -
2
The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial
Published in Respiratory research (15-09-2021)“…Abstract Background We performed a multicenter, randomized open-label trial in patients with moderate to severe Covid-19 treated with a range of possible…”
Get full text
Journal Article -
3
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
Published in BMC medicine (20-02-2024)“…The immunity induced by primary vaccination is effective against COVID-19; however, booster vaccines are needed to maintain vaccine-induced immunity and…”
Get full text
Journal Article -
4
Mortality and re-fracture rates in low trauma hip fracture
Published in BMC geriatrics (30-04-2024)“…This study aimed to estimate the incidence rate of re-fracture and all-cause mortality rate in patients with hip fractures caused by minor trauma in the first…”
Get full text
Journal Article -
5
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years
Published in BMC infectious diseases (24-02-2023)“…The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity in a phase II trial. We did a phase II, single-centered,…”
Get full text
Journal Article -
6
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial
Published in Virology journal (18-07-2023)“…We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial…”
Get full text
Journal Article -
7
Cardio-metabolic and socio-demographic risk factors associated with dependency in basic and instrumental activities of daily living among older Iranian adults: Bushehr elderly health program
Published in BMC geriatrics (09-03-2021)“…Iran's population is aging. Disability is a major public health problem for older adults, not only in Iran but all over the world. The purpose of this study…”
Get full text
Journal Article -
8
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
Published in Vaccines (Basel) (01-02-2023)“…: This study aimed to determine the safety and immunogenicity of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP). : We…”
Get full text
Journal Article -
9
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial
Published in Heliyon (15-03-2024)“…We conducted a phase III, non-inferiority trial comparing safety and efficacy of RCP recombinant spike protein Covid-19 vaccine to BBIBP (Sinopharm). Adult…”
Get full text
Journal Article -
10
Factors Affecting the Satisfaction of Healthcare Workers with the Healthcare System Reform Plan in Healthcare Networks in Bushehr Province in 2018: A Qualitative Study
Published in Ṭibb-i junūb (01-10-2020)“…Background: Evaluating and identifying existing challenges of the healthcare system reform plan can help policy makers and executives address these…”
Get full text
Journal Article -
11
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial
Published in Vaccine: X (01-12-2023)“…The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity. In this double-blind, placebo-controlled, phase I trial, we…”
Get full text
Journal Article -
12
Immunogenicity and safety of RAZI recombinant spike protein vaccine
Published in BMC medicine (20-02-2024)“…Background The immunity induced by primary vaccination is effective against COVID-19; however, booster vaccines are needed to maintain vaccine-induced immunity…”
Get full text
Journal Article -
13
Geographic distribution and time trends of water-pipe use among Iranian youth and teenage students: A meta-analysis and systematic review
Published in Journal of ethnicity in substance abuse (02-05-2023)“…Water-pipe tobacco smoking is harmful to health, yet its rate of prevalence remains uncertain. Recent evidence has shown that the prevalence of water-pipe…”
Get full text
Journal Article -
14
Study of Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province
Published in Ṭibb-i junūb (01-04-2018)“…Background: TP53 tumor suppressor gene play a role in repairing DNA damages and also in cell apoptosis. This research have paid to the association between…”
Get full text
Journal Article -
15
Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province
Published in Ṭibb-i junūb (01-04-2018)Get full text
Journal Article